LSE - Delayed Quote GBp

NetScientific plc (NSCI.L)

68.50 0.00 (0.00%)
At close: June 7 at 2:21 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,383.00
1,004.00
1,107.00
394.00
735.00
Cost of Revenue
245.00
222.00
118.00
46.00
117.00
Gross Profit
1,138.00
782.00
989.00
348.00
618.00
Operating Expense
5,562.00
5,149.00
3,922.00
2,632.00
4,091.00
Operating Income
-4,424.00
-4,367.00
-2,933.00
-2,284.00
-3,473.00
Net Non Operating Interest Income Expense
-15.00
39.00
1.00
82.00
-1.00
Pretax Income
-3,661.00
-3,711.00
-2,923.00
-2,381.00
-3,634.00
Tax Provision
-25.00
-37.00
-61.00
-43.00
-88.00
Net Income Common Stockholders
-3,064.00
-3,094.00
-2,385.00
-1,611.00
-4,491.00
Diluted NI Available to Com Stockholders
-3,064.00
-3,094.00
-2,385.00
-1,611.00
-4,491.00
Basic EPS
-0.13
-0.14
-0.13
-0.29
-0.57
Diluted EPS
-0.13
-0.14
-0.13
-0.29
-0.57
Basic Average Shares
23,437.34
22,266.56
18,050.72
5,612.94
7,856.19
Diluted Average Shares
23,437.34
22,266.56
18,050.72
5,612.94
7,856.19
Total Operating Income as Reported
-3,646.00
-3,750.00
-2,960.00
-2,463.00
-3,633.00
Rent Expense Supplemental
--
10.00
29.00
28.00
44.00
Total Expenses
5,807.00
5,371.00
4,040.00
2,678.00
4,208.00
Net Income from Continuing & Discontinued Operation
-3,064.00
-3,094.00
-2,385.00
-1,611.00
-4,491.00
Normalized Income
-3,836.69
-3,704.85
-2,393.81
-1,435.23
-3,008.87
Interest Income
65.00
94.00
23.00
110.00
21.00
Interest Expense
80.00
55.00
22.00
28.00
22.00
Net Interest Income
-15.00
39.00
1.00
82.00
-1.00
EBIT
-3,581.00
-3,656.00
-2,901.00
-2,353.00
-3,612.00
EBITDA
-3,144.00
-3,309.00
-2,653.00
-2,200.00
-3,538.00
Reconciled Cost of Revenue
245.00
222.00
118.00
46.00
117.00
Reconciled Depreciation
437.00
347.00
248.00
153.00
74.00
Net Income from Continuing Operation Net Minority Interest
-3,064.00
-3,094.00
-2,385.00
-1,611.00
-3,165.00
Total Unusual Items Excluding Goodwill
778.00
617.00
9.00
-179.00
-160.00
Total Unusual Items
778.00
617.00
9.00
-179.00
-160.00
Normalized EBITDA
-3,922.00
-3,926.00
-2,662.00
-2,021.00
-3,378.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
5.31
6.15
0.19
-3.23
-3.87
12/31/2019 - 9/16/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NFX.L Nuformix plc
0.2010
+0.50%
 
OCTP.L Oxford Cannabinoid Technologies Holdings Plc
0.1150
-4.17%
 
ROQ.L Roquefort Therapeutics plc
4.9000
0.00%
 
OXOA.F Oxford Biomedica plc
3.7400
-1.06%
 
HEMO.L Hemogenyx Pharmaceuticals Plc
1.5090
-0.40%
 
SBTX.L SkinBioTherapeutics plc
9.75
-1.27%
 
SNG.L Synairgen plc
6.66
+1.68%
 
ONT.L Oxford Nanopore Technologies plc
101.80
-1.36%
 
HVO.L hVIVO plc
27.05
+0.37%
 
FUM.L Futura Medical plc
38.35
+0.26%